Injective INJ
Current Price
$3.33 +3.01%
$0.1500 Daily Range (4.50%)
$3.23$3.38
$46.07M Daily Volume
586 BTC
Vol/MktCap: 13.84%
Market Performance
0.09% Relative BTC Volume
The total volume of Injective is $46.07M over the past 24 hours, compared to $49.15B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.34 -0.38%
13 SMA $3.34 -0.44%
21 SMA $3.32 +0.33%
55 SMA $3.30 +0.87%
144 SMA $3.31 +0.73%
Price Performance
-1.11% 1 Hour Change
$3.33 from $3.37
+0.37% 7 Day Change
$0.0123 from $3.32
+14.25% 14 Day Change
$0.4744 from $2.86
+9.14% 30 Day Change
$0.3044 from $3.03
All Time High
March 14, 2024
$52.62 -93.69%
-$49.30 vs. now
24H Change
9.74M USD +3.02%
124 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
13.94M INJ
traded over past 24 hours
13.94% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently trading at $3.36, reflecting a 2.68% increase over the past 24 hours. The price is near the daily high of $3.36, indicating strong upward momentum, while the daily low was $3.21, suggesting a relatively narrow trading range of just $0.15.
Trading volume over the past 24 hours is 48,542,167, representing a volume-to-market cap ratio of 14.48%. This substantial volume indicates increased investor interest and participation, reinforcing the current bullish trend in the market.
Short-term moving averages reveal a positive trend, with the 8 SMA at $3.34 showing a 0.58% increase and the 13 SMA at $3.32 indicating a 1.24% gain. The 21 SMA and 55 SMA both demonstrate upward movements of approximately 2.12% and 2.11%, respectively, suggesting consistent buying pressure across different time frames.
The 1-hour Relative Strength Index (RSI) is at 74, indicating that INJ may be overbought in the short term. In contrast, the 7-day RSI at 51 suggests a more neutral stance, implying that the asset is not overextended over a longer period, which could provide room for further upside.
Over the past week, INJ has appreciated by 9.66%, while the 14-day and 30-day changes are 12.08% and 9.81%, respectively. This consistent upward movement indicates a solid bullish trend in the medium term, although caution is warranted given the short-term RSI levels.
Injective's all-time high of $52.62, achieved in March 2024, indicates substantial long-term potential. However, current price levels are significantly lower, suggesting a long path for recovery to those peaks, while also highlighting the volatility inherent in the cryptocurrency market.
Given the current data, including strong volume, favorable short-term moving averages, and a bullish medium-term trend, the recommendation for INJ is a Buy. The short-term overbought condition may lead to a slight pullback, but the overall bullish sentiment and upward price trajectory make it an attractive investment opportunity.
Trading volume over the past 24 hours is 48,542,167, representing a volume-to-market cap ratio of 14.48%. This substantial volume indicates increased investor interest and participation, reinforcing the current bullish trend in the market.
Short-term moving averages reveal a positive trend, with the 8 SMA at $3.34 showing a 0.58% increase and the 13 SMA at $3.32 indicating a 1.24% gain. The 21 SMA and 55 SMA both demonstrate upward movements of approximately 2.12% and 2.11%, respectively, suggesting consistent buying pressure across different time frames.
The 1-hour Relative Strength Index (RSI) is at 74, indicating that INJ may be overbought in the short term. In contrast, the 7-day RSI at 51 suggests a more neutral stance, implying that the asset is not overextended over a longer period, which could provide room for further upside.
Over the past week, INJ has appreciated by 9.66%, while the 14-day and 30-day changes are 12.08% and 9.81%, respectively. This consistent upward movement indicates a solid bullish trend in the medium term, although caution is warranted given the short-term RSI levels.
Injective's all-time high of $52.62, achieved in March 2024, indicates substantial long-term potential. However, current price levels are significantly lower, suggesting a long path for recovery to those peaks, while also highlighting the volatility inherent in the cryptocurrency market.
Given the current data, including strong volume, favorable short-term moving averages, and a bullish medium-term trend, the recommendation for INJ is a Buy. The short-term overbought condition may lead to a slight pullback, but the overall bullish sentiment and upward price trajectory make it an attractive investment opportunity.
Updated 378 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

Bitcoin: Will Trump’s ceasefire extension keep BTC price range-bound?
Bitcoin stalls as buyers and sellers pull back, leaving the market primed for a sharp move.

SpaceX Warns Investors Elon Musk’s Space-Based AI Data Centers May Not Pay Off
SpaceX’s IPO filing says orbital AI computing remains unproven and commercially uncertain despite Musk’s public push for space as AI’s next frontier.

Gold Price Today: Bulls Reclaim $4,770 but Bearish Pressure Lingers
Gold is going into the day with an ambivalent technical position.

Coinbase lists GBP-backed stablecoin tGBP as UK pushes for crypto growth
tGBP goes live on Coinbase, bringing GBP-denominated stablecoin access to global users.